Cargando…
Identification of a TPP1 Q278X Mutation in an Iranian Patient with Neuronal Ceroid Lipofuscinosis 2: Literature Review and Mutations Update
Neuronal ceroid lipofuscinoses type 2 (CLN2), the most common form of Batten disease, is caused by TPP1 loss of function, resulting in tripeptidyl peptidase-1 enzyme deficiency and cerebral accumulation of lipopigments. Clinical hallmarks include epileptic seizures, vision loss, progressive movement...
Autores principales: | Baranzehi, Tayebeh, Kordi-Tamandani, Dor Mohammad, Najafi, Maryam, Khajeh, Ali, Schmidts, Miriam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653935/ https://www.ncbi.nlm.nih.gov/pubmed/36362641 http://dx.doi.org/10.3390/jcm11216415 |
Ejemplares similares
-
Mutation update: Review of TPP1 gene variants associated with neuronal ceroid lipofuscinosis CLN2 disease
por: Gardner, Emily, et al.
Publicado: (2019) -
Generation of pathogenic TPP1 mutations in human stem cells as a model for neuronal ceroid lipofuscinosis type 2 disease
por: Ma, Li, et al.
Publicado: (2021) -
Mutated CTSF in adult-onset neuronal ceroid lipofuscinosis and FTD
por: van der Zee, Julie, et al.
Publicado: (2016) -
Editorial: Neuronal ceroid lipofuscinosis: A multidisciplinary update
por: Simonati, Alessandro, et al.
Publicado: (2022) -
Novel CLN1 mutation with atypical juvenile neuronal ceroid lipofuscinosis
por: Khan, Arif, et al.
Publicado: (2013)